β³ Fetching live dividend data...
Home βΊ Calculator βΊ HROW Dividend Calculator 2026
Harrow Health, Inc. Β· NASDAQ
Price: $40.44 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HROW β $10.75M in 10 years Β· $43.28/month
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open HROW position with:
Real after-tax yield depends on where you live and how you hold HROW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 4.95% | 2.15% | $495 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 4.21% | 1.41% | $421 / yr |
| πΊπΈ US Taxable (20%) | 20% | 3.96% | 1.16% | $396 / yr |
| π¬π§ UK ISA | 0% | 4.95% | 2.15% | $495 / yr |
| π¬π§ UK Taxable | 8.75% | 4.52% | 1.72% | $452 / yr |
| π¨π¦ TFSA | 0% | 4.95% | 2.15% | $495 / yr |
| π¨π¦ CA Taxable | 25% | 3.71% | 0.91% | $371 / yr |
| π¦πΊ Super (pension) | 15% | 4.21% | 1.41% | $421 / yr |
| π¦πΊ AU Taxable | 30% | 3.46% | 0.67% | $347 / yr |
| π©πͺ DE Taxable | 26.375% | 3.64% | 0.84% | $364 / yr |
| π«π· FR Taxable | 30% | 3.46% | 0.67% | $347 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
HROW pays quarterly β 4 times per year. Next ex-div: TBD.
How HROW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HROW sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-08-14 | 11,250 | $35.96 | $404.6K | ||
| M-Exempt | 2026-08-14 | 11,250 | $35.96 | $404.6K | ||
| Sale | 2026-08-14 | 11,250 | $40.00 | $450.0K | ||
| A-Award | 2026-06-18 | 5,248 | β | β | ||
| A-Award | 2026-06-18 | 5,248 | β | β | ||
| A-Award | 2026-06-18 | 5,248 | β | β | ||
| Buy | 2026-05-18 | 1,000 | $31.07 | $31.1K | ||
| Buy | 2026-05-18 | 1,000 | $31.00 | $31.0K | ||
| A-Award | 2026-05-15 | 10,000 | β | β | ||
| Buy | 2026-05-14 | 10,000 | $30.20 | $302.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HROW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Harrow Health, Inc. (HROW) is currently trading at $40.44, 25% below its 52-week high. The current dividend yield is 4.95% based on an annual payout of $2.00 per share.
Harrow Health, Inc. (HROW) is a healthcare stock currently trading at $40.44 with a dividend yield of 4.95%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever